Literature DB >> 14505210

Vascular damage and lack of angiogenesis in systemic sclerosis skin.

Y T Konttinen1, Z Mackiewicz, P Ruuttila, A Ceponis, A Sukura, D Povilenaite, M Hukkanen, I Virtanen.   

Abstract

The aim of this study was to analyse microvascular damage and compensatory angiogenesis in skin from patients with systemic sclerosis (SSc) compared with systemic lupus erythematosus (SLE), Raynaud's phenomenon (RP) and healthy controls. Immunohistochemistry was used for skin biopsies (9 SSc, 10 SLE, 9 RP and 12 healthy controls) using von Willebrand factor and beta3 integrin subunit specific antibodies, TechMate immunostaining robot and biotin-streptavidin protocol. In the early stages of SSc, vWF was found in the perivascular space and interstitial matrix in papillary but not in the reticular dermis, in particular around small oedematous blood vessels infiltrated by mononuclear cells. The extravascular release of vWF in SSc specimens was associated with weak or even a total lack of immunoreactivity within the associated endothelial cells. Late stages of SSc were characterised by loss of the dermal papillae, subepidermal fibrosis, hypovascularity and strong endothelial vWF expression without extravascular leakage. In all SSc patients studied only a few vascular profiles were weakly immunostained for beta3 integrin subunit. This work demonstrates that vWF is not only released into the systemic circulation, but is also leaked to the perivascular space/matrix. This local release and deposition of vWF is probably a sensitive and early marker of microvascular involvement in SSc pathogenesis. Local vWF release may play a role in platelet adhesion, aggregation, thrombogenesis and dermal connective tissue remodelling. In spite of some attempts towards compensatory angiogenesis in SSc, as evidenced by beta3 integrin subunit expression, it was evident that the angiogenic response was not able to prevent the development of hypovascularity during the advanced stages of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505210     DOI: 10.1007/s10067-003-0698-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

Review 1.  [Angiogenesis. Possibilities for therapeutic intervention in rheumatic diseases].

Authors:  B Maurer; J H W Distler; F Moritz; S Gay; O Distler
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

Review 2.  A vascular mechanistic approach to understanding Raynaud phenomenon.

Authors:  Nicholas A Flavahan
Journal:  Nat Rev Rheumatol       Date:  2014-12-23       Impact factor: 20.543

3.  Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function.

Authors:  Tadeusz M Zielonka; U Demkow; E Radzikowska; B Bialas; M Filewska; K Zycinska; M H Obrowski; J Kowalski; K A Wardyn; E Skopinska-Rozewska
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

4.  Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects.

Authors:  Antonio Aversa; Roberto Bruzziches; Davide Francomano; Edoardo Rosato; Felice Salsano; Giovanni Spera
Journal:  Int J Rheumatol       Date:  2010-10-05

5.  Histomorphometrical analysis of microvascular abnormalities in connective tissue diseases.

Authors:  Axel von Bierbrauer; Jörg Willert; Peter Barth
Journal:  Rheumatol Int       Date:  2007-07-27       Impact factor: 2.631

Review 6.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 7.  UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review.

Authors:  Frank Breuckmann; Thilo Gambichler; Peter Altmeyer; Alexander Kreuter
Journal:  BMC Dermatol       Date:  2004-09-20

Review 8.  Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.

Authors:  Mirko Manetti; Serena Guiducci; Lidia Ibba-Manneschi; Marco Matucci-Cerinic
Journal:  J Cell Mol Med       Date:  2010-01-30       Impact factor: 5.310

Review 9.  Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis.

Authors:  Alisa E Koch; Oliver Distler
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  MMP-12 deficiency attenuates angiotensin II-induced vascular injury, M2 macrophage accumulation, and skin and heart fibrosis.

Authors:  Lukasz Stawski; Paul Haines; Alan Fine; Lidia Rudnicka; Maria Trojanowska
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.